These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11130318)

  • 21. Issues facing TB control (6). Tuberculosis control in sub-Saharan Africa in the face of HIV and AIDS.
    Harries AD
    Scott Med J; 2000 Oct; 45(5 Suppl):47-50; discussion 51. PubMed ID: 11130317
    [No Abstract]   [Full Text] [Related]  

  • 22. Tuberculosis control: the relevance of classic principles in an era of acquired immunodeficiency syndrome and multidrug resistance.
    Kaye K; Frieden TR
    Epidemiol Rev; 1996; 18(1):52-63. PubMed ID: 8877330
    [No Abstract]   [Full Text] [Related]  

  • 23. Paediatric chemoprophylaxis for child contacts of drug-resistant tuberculosis cases: Are current guidelines effective in preventing disease?
    Padayatchi N; Naidu N
    S Afr Med J; 2015 Jul; 105(5):328-9. PubMed ID: 26242645
    [No Abstract]   [Full Text] [Related]  

  • 24. 'Universal' access for MDR-TB limited without the involvement of the private sector.
    Pinto L; Udwadia Z
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):851; author reply 851-2. PubMed ID: 21575312
    [No Abstract]   [Full Text] [Related]  

  • 25. [Managing multidrug-resistant tuberculosis].
    Antoun F; Véziris N
    Rev Mal Respir; 2011 Oct; 28(8):956-7. PubMed ID: 22099400
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of multidrug resistance on global tuberculosis control.
    Cox H; Hargreaves S; Ismailov G
    Lancet; 2003 Nov; 362(9398):1858-9. PubMed ID: 14654338
    [No Abstract]   [Full Text] [Related]  

  • 27. XDR tuberculosis--implications for global public health.
    Raviglione MC; Smith IM
    N Engl J Med; 2007 Feb; 356(7):656-9. PubMed ID: 17301295
    [No Abstract]   [Full Text] [Related]  

  • 28. Antituberculosis drug resistance worldwide.
    Wkly Epidemiol Rec; 1998 Aug; 73(33):249-54. PubMed ID: 9763933
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs.
    Zumla A; Abubakar I; Raviglione M; Hoelscher M; Ditiu L; McHugh TD; Squire SB; Cox H; Ford N; McNerney R; Marais B; Grobusch M; Lawn SD; Migliori GB; Mwaba P; O'Grady J; Pletschette M; Ramsay A; Chakaya J; Schito M; Swaminathan S; Memish Z; Maeurer M; Atun R
    J Infect Dis; 2012 May; 205 Suppl 2():S228-40. PubMed ID: 22476720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk for multidrug-resistant tuberculosis in migratory workers, Armenia.
    Truzyan N; Crape B; Grigoryan R; Martirosyan H; Petrosyan V
    Emerg Infect Dis; 2015 Mar; 21(3):474-6. PubMed ID: 25695488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gains in tuberculosis control at risk due to 3 million missed patients and drug resistance. Progress in TB control can be substantially accelerated by addressing these challenges.
    Cent Eur J Public Health; 2013 Dec; 21(4):236-7. PubMed ID: 24592733
    [No Abstract]   [Full Text] [Related]  

  • 33. [Tuberculosis a threat again. Multiresistance in the Baltic States and in Russia; Nordic countries initiate cooperation to prevent transmission].
    Rutqvist A; Boman G; Ekdahl K; Hoffner S; Julander I; Larsson LO; Ridell M
    Lakartidningen; 2000 Nov; 97(48):5606-10. PubMed ID: 11187376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An integrated MDR-TB management programme results in favourable outcomes in northern Taiwan.
    Yu MC; Chen HY; Chien SH; Jou R
    Eur Respir J; 2015 Jan; 45(1):272-5. PubMed ID: 25102959
    [No Abstract]   [Full Text] [Related]  

  • 35. XDR-TB or not XDR-TB? That is the question.
    Bateman C
    S Afr Med J; 2007 May; 97(5):318, 320, 322. PubMed ID: 17599208
    [No Abstract]   [Full Text] [Related]  

  • 36. [Multidrug resistant tuberculosis -- its extent, hazard and possible solutions].
    Zellweger JP
    Rev Mal Respir; 2011 Oct; 28(8):1025-33. PubMed ID: 22099408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fight against tuberculosis in the world].
    El Kamel A; Joobeur S; Skhiri N; Cheikh Mhamed S; Mribah H; Rouatbi N
    Rev Pneumol Clin; 2015; 71(2-3):181-7. PubMed ID: 24878188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stop TB Partnership has provided treatments for 10 million people in 6 years.
    Wkly Epidemiol Rec; 2007 Jun; 82(22/23):206-7. PubMed ID: 17542093
    [No Abstract]   [Full Text] [Related]  

  • 39. F-A-S-T: a refocused, intensified, administrative tuberculosis transmission control strategy.
    Barrera E; Livchits V; Nardell E
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):381-4. PubMed ID: 25859991
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug-resistant tuberculosis: mechanisms and management.
    Hayward CM; Herrman JL; Griffin GE
    Br J Hosp Med; 1995 Nov 15-Dec 12; 54(10):494-500. PubMed ID: 8574491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.